Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
2,884
datasets available to search
ShareScore release 0.9.0
Dataset results
2,884 results for “cancer resistance”
ESK981 and Nivolumab for the Treatment of Metastatic Castration Resistant Prostate Cancer
ClinicalTrials.gov study NCT04159896. IPD Sharing: NO. Countries: 1. Publications: 1.
A Phase III Trial of ZD4054 (Zibotentan) (Endothelin A Antagonist) and Docetaxel in Metastatic Hormone Resistant Prostate Cancer
ClinicalTrials.gov study NCT00617669. IPD Sharing: Not stated. Countries: 26. Publications: 1.
BLM overexpression as a predictive biomarker for CHK1 inhibitor response in PARP inhibitor–resistant BRCA-mutant ovarian cancer
Open the record for dataset details and reuse information.
Data from: Aberrant FGFR signaling mediates resistance to CDK4/6 inhibitors in ER+ breast cancer
Open the record for dataset details and reuse information.
Supplementary material: CYB561 supports the neuroendocrine phenotype in castration-resistant prostate cancer
Open the record for dataset details and reuse information.
Biomarkers in Metastatic Castration-Resistant Prostate Cancer for efficiency of Immune Checkpoint Inhibitors
Open the record for dataset details and reuse information.
Colorectal cancer patients-derived immunity-organoid platform unveils cancer-specific tissue markers associated with immunotherapy resistance.
Open the record for dataset details and reuse information.
NanoString dataset for study: Dynamic changes in the NK-, Neutrophil-, and B-cell immunophenotypes relevant in high metastatic risk post neoadjuvant chemotherapy–resistant early breast cancers
<p>Pre-processed DSP and mRNA abundance datasets used in this study.</p>
Data and Code for "Genomic mechanisms of resistance to tyrosine kinase inhibitors in HER2 amplified breast cancer"; Parsons et al. 2024
<p>Data and code for the manuscript <em>Genomic mechanisms of resistance to tyrosine kinase inhibitors in HER2 amplified breast cancer</em> (Parsons et al. 2024).</p> <p>Data: `parsons_her2_tki_data.tar.gz`</p> <p>Code: `parsons_her2_tki_code.tar.gz`</p> <p>The code may also be obtained from our GitHub repository:<br>https://github.com/getzlab/parsons_her2_tki_manuscript<br><br><br></p>
Fig. 10 in Diterpenoids from Euphorbia royleana reverse P-glycoprotein-mediated multidrug resistance in cancer cells
Fig. 10. Binding pose of 15 with human Pgp. The P-gp model was generated based on the PDB structure of human P-gp (Code: 6QEX) and was portrayed as a cartoon (light green). Residues involved in the interaction were colored yellow, while the surfaces of the hydrophobic pocket packing with 15 were colored light brown red. The hydrogen bonds and hydrophobic forces were shown as red dashed lines and yellow dashed lines, respectively. The structural figures were drawn in Accelrys Discovery Studio 2016. (For interpretation of the references to color in this figure legend, the reader is referred to the Web version of this article.)
Fig. 9 in Diterpenoids from Euphorbia royleana reverse P-glycoprotein-mediated multidrug resistance in cancer cells
Fig. 9. (A) Inhibitory effects of 15 on the accumulation of rhodamin-123 (Rho-123) in HepG2/DOX. (B) Inhibitory effects of 15 on the efflux of Rho-123 in HepG2/ DOX. Scale bar = 200 μm.
Fig. 7 in Diterpenoids from Euphorbia royleana reverse P-glycoprotein-mediated multidrug resistance in cancer cells
Fig. 7. Mediated multidrug resistance (MDR)-reversing effects of the compounds on doxorubicin (DOX)-resistant human hepatocellular carcinoma cell line (HepG2/ DOX).
Fig. 6 in Diterpenoids from Euphorbia royleana reverse P-glycoprotein-mediated multidrug resistance in cancer cells
Fig. 6. Experimental ECD spectrum of 3 (red line) and calculated ECD spectra (200–400 nm) of (3S,4S,5R,8S,10S,11R,13R,14R,15R)-3a (black line) and (3R,4R,5S,8R,10R,11S,13S,14S,15S)-3b (blue line). (For interpretation of the references to color in this figure legend, the reader is referred to the Web version of this article.)
Fig. 5 in Diterpenoids from Euphorbia royleana reverse P-glycoprotein-mediated multidrug resistance in cancer cells
Fig. 5. Experimental CD spectrum (red line) of compound 2, and the Rh2(OCOCF3)4 induced CD spectrum (black line) of 2 in CH2Cl2 for 190–450 nm (left), and the applied bulkiness rule for secondary alcohols (right). (For interpretation of the references to color in this figure legend, the reader is referred to the Web version of this article.)
A Phase I/II Trial of VB-111 and Paclitaxel for Recurrent Platinum-Resistant Müllerian Cancer
ClinicalTrials.gov study NCT01711970. IPD Sharing: Not stated. Countries: 1. Publications: 1.
OVATURE (OVArian TUmor REsponse) A Phase III Study of Weekly Carboplatin With and Without Phenoxodiol in Patients With Platinum-Resistant, Recurrent Epithelial Ovarian Cancer
ClinicalTrials.gov study NCT00382811. IPD Sharing: Not stated. Countries: 7. Publications: 1.
Comparative Study of Abiraterone Acetate Tablets (I) or ZYTIGA® in Patients With Metastatic Castration-resistant Prostate Cancer
ClinicalTrials.gov study NCT04862091. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Efficacy and Safety Study of Sorafenib With Topotecan in Patients With Platinum-resistant Recurrent Ovarian Cancer
ClinicalTrials.gov study NCT01047891. IPD Sharing: Not stated. Countries: 1. Publications: 2.
FOcus on Reducing Dose-limiting Toxicities in Colon Cancer With Resistance Exercise Study
ClinicalTrials.gov study NCT03291951. IPD Sharing: NO. Countries: 1. Publications: 3.
Fractionated Docetaxel and Radium 223 in Metastatic Castration-Resistant Prostate Cancer
ClinicalTrials.gov study NCT03737370. IPD Sharing: NO. Countries: 1. Publications: 12.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.